Solo Brands, Inc.

Solo Brands, Inc.

SBDS
Solo Brands, Inc.US flagOther OTC
4.08
USD
-0.12
- -
10.45MMarket Cap
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
25.94
82.94
256.28
326.26
327.12
311.4
200.24
163.89
Basic EPS, GAAP
-19.22
13.98
30.89
-3.12
-73.62
-77.66
-64.09
-51.3
Free Cash Flow per Basic Share
-12.97
19.82
-6.5
20.42
41.27
7.2
-29.48
6.79
Dividend per Share
2.57
10.75
21.05
- -
- -
- -
1.58
- -
Book Value per Share
48.26
216.13
6.85
3.68
-76.27
-156.75
-208.7
-181.9
Tangible Book Value per Share
-12.26
-102.56
-59.43
-26.66
-12.16
-51.28
-83.06
-67.48
Basic Weighted Avg Shares
2
2
2
2
2
1
2
2
Sales/Revenue/Turnover
40
127
404
518
495
455
317
302
Operating Margin (%)
-71.93
12.67
17.06
5.98
4.27
-8.47
-6.31
-6.49
Depreciation Expense
1
5
18
25
27
27
29
27
Net Income, GAAP
-30
21
49
-5
-111
-113
-101
-95
Effective Tax Rate (%)
- -
0.24
3.46
- -
- -
- -
- -
- -
Profit Margin (%)
-74.12
16.85
12.05
-0.96
-22.5
-24.94
-32
-31.3
Working Capital
5
-86
112
128
108
51
93
106
LT Debt
24
73
125
138
169
165
254
274
Total Equity
74
332
574
575
372
193
51
46
Return on Invested Capital (%)
- -
6.37
11.88
- -
- -
- -
- -
- -
Return on Capital (%)
- -
11.84
10.77
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
10.57
28.38
-59.48
- -
- -
- -
- -

Capital Structure

FRC

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
8
8
8
LT Borrowings
234
240
261
LT Finance Leases
16
14
13
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
2
2
3
Market Capitalization
23
10
7

Working Capital

FRC

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
128
140
148
Cash, Cash Equivalents & STI
16
20
16
Accounts Receivable, Net
16
30
39
Inventories
85
84
83
Total Current Liabilities
40
47
42
Payables & Accruals
25
27
19
ST Debt
8
8
8
Deferred Revenue
1
2
2

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
-16.74%
-73.42%
Free Cash Flow
- -
-216.68%
-543.11%
Net Income, GAAP
- -
431.86%
-10.62%
Sales/Revenue/Turnover
- -
40.42%
-30.35%
Total Cash Common Dividend
- -
- -
-92.46%

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
85
132
94
144
455
2025
77
92
53
94
317
2026
63
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-2.34
-2.13
-47.72
-25.22
-77.66
2025
-8.27
-8.93
-9.22
-35.03
-64.09
2026
-2.18
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
1.58
2026
- -
- -
- -
- -
- -

Company Description

MCPAPIChat
CEO
John Larson
Full Time Employees
526
Sector
Consumer Cyclical
Industry
Specialty Retail
Address
1001 Mustang Drive Grapevine TX United States of America 76051
IPO Date
Jun 28, 2021
Business
Solo Brands, Inc. Solo Brands, Inc. (NYSE: SBDS) operates a direct-to-consumer and omnichannel platform offering premium outdoor lifestyle and apparel products primarily in the United States. The company provides camp stoves under the Solo Stove Lite brand; fire pits, grills, pizza ovens, and accessories under the Solo Stove and TerraFlame brands; folding kayaks and accessories under the Oru brand; inflatable and hard paddle boards under the ISLE brand; and swim trunks, casual shorts, polos, shirts, and lounge products under the Chubbies brand, along with consumables such as color packs, starters, natural charcoal, fuel, pellets, and firewood. Founded in 2011 and headquartered in Grapevine, Texas, Solo Brands serves outdoor enthusiasts, homeowners, campers, urban adventurers, water sports participants, and casual apparel consumers through e-commerce, strategic retail partnerships, and physical stores. Recent developments include a 1-for-40 reverse stock split and ticker change to SBDS in July 2025 following NYSE trading resumption; a June 2025 refinancing with a $240 million term loan and $90 million revolving credit facility that eliminated going-concern doubts; restructuring initiatives such as winding down IcyBreeze, consolidating Oru and ISLE operations, and significant cost reductions yielding $11 million in Q3 2025 operating cash flow; launches of Summit 24 and Infinity Flame firepits gaining traction; and segment shifts emphasizing Solo Stove and Chubbies amid Q3 2025 net sales of $53 million.

Company News

MCPAPIChat
  • Solo Brands, Inc. to Present and Host 1x1 Meetings at the 16th Annual East Coast IDEAS Investor Conference on June 11, 2026

  • Solo Brands, Inc. (SBDS) Q1 2026 Earnings Call Transcript

  • Solo Brands, Inc. Announces Fiscal 2026 First Quarter Results

  • Solo Brands, Inc. Fiscal 2026 First Quarter Results To Be Released Thursday, May 14, 2026

  • NYSE to Commence Delisting Proceedings Against Solo Brands, Inc. (SBDS)

  • Solo Stove Partners with Rice Krispies Treats to Redefine Summer's Ultimate Roasting Experience

  • Solo Brands, Inc. Issues Fiscal Year 2026 Financial Guidance

  • Solo Brands, Inc. (SBDS) Q4 2025 Earnings Call Transcript

  • Solo Brands Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

  • Solo Brands, Inc. Announces Fiscal 2025 Fourth Quarter and Full Year Results

  • Solo Brands, Inc. to Host 1x1 Meetings at the 38th Annual Roth Conference on March 23-24, 2026

  • Canacol Energy Announces Leadership Change and Independent Director Appointment

  • Chubbies Announces the Launch of Cheekies, Its New Women's Swim Brand

  • Solo Stove "Squashes the Beef at the Big Game," Turning Rivalries into Connection Over Fire and Food

  • Solo Brands, Inc. Provides Commentary on Preliminary Fiscal 2025 Fourth Quarter Results and Timing of its Full Year and Fourth Quarter Fiscal 2025 Financial Results and Conference Call

  • Solo Brands, Inc. Announces Corporate Simplification to Establish a Single Class of Common Stock and Limit Its Tax Receivable Agreement

  • Nike to report Q2 earnings amid weak DTC trends, mixed sentiment

  • Metalsource Mining Announces Eligibility for Depository Trust Company (DTC) Services

  • Defence Therapeutics Announces Formation of Scientific Advisory Board to Guide Advancement of Accum-Enhanced Antibody Drug Conjugate Programs

  • Defence Therapeutics Announces Convertible Debenture Conversion